IRIS
BERNASCONI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.396
EU - Europa 4.175
AS - Asia 3.040
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
OC - Oceania 3
Totale 12.629
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.357
CN - Cina 2.964
UA - Ucraina 1.003
IE - Irlanda 987
FI - Finlandia 569
DE - Germania 531
SE - Svezia 429
IT - Italia 356
GB - Regno Unito 162
FR - Francia 85
SG - Singapore 39
CA - Canada 38
JP - Giappone 17
BE - Belgio 15
NL - Olanda 13
RU - Federazione Russa 10
IN - India 8
IR - Iran 7
RO - Romania 7
EU - Europa 5
MU - Mauritius 4
AU - Australia 3
BR - Brasile 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IL - Israele 2
MN - Mongolia 2
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
MD - Moldavia 1
MX - Messico 1
PT - Portogallo 1
PY - Paraguay 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 12.629
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.240
Chandler 1.080
Dublin 987
Nanjing 949
Nanchang 413
Ashburn 382
Shenyang 270
Princeton 263
Lawrence 262
Hebei 254
Changsha 247
Wilmington 228
Jiaxing 206
Medford 179
Boardman 172
Tianjin 146
Hangzhou 137
New York 122
Beijing 114
Ann Arbor 109
Milan 81
Helsinki 76
Woodbridge 50
Norwalk 48
Shanghai 43
Verona 39
Toronto 34
Seattle 28
Jinan 26
Singapore 26
Des Moines 24
Fairfield 23
Kunming 21
Los Angeles 21
Pavia 21
Zhengzhou 20
Ningbo 18
Tokyo 17
Brussels 15
Washington 13
Falls Church 12
Houston 11
Lanzhou 10
Rome 10
Taizhou 10
Auburn Hills 9
Fuzhou 9
Guangzhou 9
Novokuznetsk 7
Orange 7
Changchun 6
Meppel 6
Pune 6
Redwood City 6
Bergamo 5
Borås 5
Palermo 5
Andover 4
Bologna 4
Monmouth Junction 4
Tappahannock 4
Taranto 4
Zanjan 4
Ardabil 3
Cologno Monzese 3
Esslingen am Neckar 3
Florence 3
Leawood 3
Mozzecane 3
Pescara 3
Turi 3
Aragona 2
Berlin 2
Bisacquino 2
Cava 2
Dearborn 2
Guanzate 2
Haikou 2
Lamporo 2
Melbourne 2
Piscataway 2
Poggio Mirteto 2
Ponte San Pietro 2
Porto 2
Rescaldina 2
San Francisco 2
Tel Aviv 2
Torino 2
Triggiano 2
Abbiategrasso 1
Besozzo 1
Bianco 1
Brno 1
Bulandshahr 1
Cagliari 1
Calderara di Reno 1
Capannelle 1
Carpaneto 1
Castelbuono 1
Castelnuovo 1
Totale 8.632
Salva come PNG Salva come JPEG
Nome #
FISH vantaggi e svantaggi 106
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 91
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 86
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 85
La citogenetica e la biologia molecolare nella valutazione del chimerismo e della malattia minima residua 80
Alcaloidi della vinca e dell'epipodofillotossina 79
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution. 77
Impiego della citosina a basse dosi: risultati global 76
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 76
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 75
Blast phase of essential thrombocythemia: A single center study. 71
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 71
Valutazione prognostica dele sindromi mielodisplastiche 71
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 70
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 70
Analisi citogenetica e molecolare in onco-ematologia: rilevanza per diagnosi, prognosi e scelte terapeutiche 70
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 70
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma 69
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 69
[Multiple myeloma localized in the superior maxillary. Description of an uncommon case]. 68
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 68
Central nervous system relapse in acute promyelocytic leucemia 67
Leucemia mielomonocitica cronica 67
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 66
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 66
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma 66
Significance of MLC for BMT with serological HLA-identical related and unrelated donors 66
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 65
Iperplasia gengivale da Ciclosporina-A nel paziente emopatico: considerazioni cliniche 65
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 64
A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia. 64
Acute nonlymphocytic leukemia : evidence of clonogenic cells in perypheral blood early in complete remission 64
Alterazioni del cariotipo nelle sindromi mielodisplastiche: significato patologico e clinico 64
Acute myeloid leukemia and diabetes insipidus: results in five patients 64
Importanza clinica della malattia minima residua nel post-trapianto” Progetto “Progressi in Biologia e Medicina 63
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 63
Selezione delle cellule CD 34 positive. 63
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 63
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 62
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma 62
Autoimmunita’ nella malattia da trapianto contro l’ospite 62
Treatment of relapsed and refractory acute myloid leukemia in adults 62
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 62
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 61
Rischio infettivologico in pazienti affetti da leucemia acuta e sottoposti a trapianto di midollo osseo autologo. Studio di 14 casi 61
Il controllo odontostomatologico nel paziente affetto da emopatia maligna: studio preliminare 61
Controllo delle infezioni nelle leucemie acute 61
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. 60
Exercise intolerance at high altitude (5050 m): critical power and W'. 60
Molecularly targeted therapy in acute myeloid leukemia. 59
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 59
Interessamento del cromosoma 3 nelle mielodisplasie (MDS) 59
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 58
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 58
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 58
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 57
Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma. 57
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 57
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 57
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 57
Telomero e telomerasi:biologia e osservazioni preliminari nelle neoplasie ematologiche 56
INQUADRAMENTO PROGNOSTICO DELLE SMD 56
IL SISTEMA TELOMERO/TELOMERASI: UN NUOVO BERSAGLIO IN EMATOLOGIA/ONCOLOGIA 56
Evolving approaches with alpha interferon in chronic myelogenous leukemia 56
Trapianto di midollo osseo nelle sindromi mielodisplastiche e nelle leucemie acute evolute da sindrome mielodisplastica 56
Alterazioni citogenetiche nelle leucemie linfatiche croniche 56
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 56
Classificazione citogenetica delle LAM: impatto prognostico e terapeutico 55
Growth factors in the therapy of myelodisplasia: biological aspects. 55
Role of the molecular staging and response in the management of follicular lymphoma patients 55
Raccolta di cellule staminali emopoietiche da sangiue periferico dopo chemioterapia nella leucemia mieloide acuta 55
Burkitt’s lymphoma/leukemia : a clinico-pathologic study on 24 adult patients. 55
Fattori di crescita emopoietici (G-CSF e GM-CSF) nel trapianto di midollo osseo allogenico 55
Alterazioni citogenetiche nelle leucemie acute 55
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 55
ABL1 amplification in T-cell acute lymphoblastic leukemia. 55
Hematopoietic growth factors in bone marrow transplantation 54
Modalità di crescita delle CFU-GM in pazienti affetti da LMC in rapporto a differenti tipi di siero 54
Il contributo della citogenetica e della ibridazione in situ nella valutazione della MRD nelle emopatie 54
Mielodiplasia secondarie a prgressa terapia antineoplastica 54
Growth of human hemopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor 54
FuseFISH: Robust detection of transcribed gene fusions in single cells 54
MECCANISMI MOLECOLARI E CELLULARI DELLA TRASFORMAZIONE LEUCEMICA NELLE SMD 54
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making 53
Bone Marrow transplantation from unrelated donors in myelodysplastic syndromes 53
Crioglobulinemie: manifestazioni cliniche 53
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 53
Complicanze emorragiche e trombotiche nel paziente chirurgico 53
Etoposide : il citostatico della linea monocitica 53
Storia naturale e trasformazione istologico/clinica dei linfomi a bassa malignita’. 53
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 53
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 53
Alternative Splicing of hTERT: a further Mechanism for the Control of Active hTERT in Acute Myeloid Leukaemia 53
Targeting Ubiquitin in cancers 52
Porpora trombocitopenica immunologica cronica in gravidanza 52
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 52
Mitoxantrone: clinical safety and tolerance in hematologic malignancies 52
World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. 51
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 51
Nephrotic sindrome after allogeneic hemopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 51
Totale 6.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.583 1.037 1.569 3 189 6 208 34 211 5 279 40 2
2020/20211.825 222 178 58 193 7 243 6 264 63 270 265 56
2021/20221.017 14 7 37 15 26 64 19 82 61 23 156 513
2022/20233.186 364 205 7 261 396 369 0 221 1.202 25 84 52
2023/20241.139 102 214 31 110 113 401 9 65 11 34 14 35
2024/202544 44 0 0 0 0 0 0 0 0 0 0 0
Totale 12.747